Healthcare sub-verticals
Stressline covers 15 healthcare B2B sub-verticals with 241 confirmed failures. Coverage ranges from 33 entries (Healthcare B2B (Other)) to 8 entries (Prior Authorization).
Coverage by sub-vertical
Sub-verticals with 20 or more confirmed failures are classified as saturated — the corpus has enough density to generate reliable structural risk signals. Sub-verticals below that threshold produce directional findings only.
Healthcare B2B (Other)
saturatedTop pattern: Ran out of money before clinical trials
33
14%
Care Coordination
saturatedTop pattern: Couldn't get paid by insurance
24
10%
Clinical Workflow
saturatedTop pattern: Couldn't get paid by insurance
23
10%
Health Insurance
below thresholdTop pattern: Couldn't get paid by insurance
17
7%
Telehealth Infrastructure
below thresholdTop pattern: Outspent by bigger competitors
15
6%
Primary Care
below thresholdTop pattern: Customer acquisition costs too high
15
6%
Digital Therapeutics
below thresholdTop pattern: Couldn't get paid by insurance
15
6%
Compliance & Regulatory
below thresholdTop pattern: Regulation moved faster than the company
14
6%
Revenue Cycle Management
below thresholdTop pattern: Customer acquisition costs too high
14
6%
Credentialing
below thresholdTop pattern: Outspent by bigger competitors
14
6%
Care Navigation
below thresholdTop pattern: Outspent by bigger competitors
13
5%
Behavioral Health
below thresholdTop pattern: Couldn't get paid by insurance
12
5%
Pharmacy Technology
below thresholdTop pattern: Outspent by bigger competitors
12
5%
Health Data Integration
below thresholdTop pattern: Outspent by bigger competitors
12
5%
Prior Authorization
below thresholdTop pattern: Outspent by bigger competitors
8
3%
What sub-vertical coverage means
A saturated sub-vertical — 20 or more confirmed failures — gives the structural matcher enough precedent to identify dominant failure patterns with high confidence. The prosecution charge is constrained to nodes with at least 3 matching entries in your sub-vertical. Below that threshold, the node is flagged as having insufficient precedent and the evidence depth tier drops to THIN.
Sub-verticals below the saturation threshold still produce useful structural analysis. The findings are directional rather than definitive: the corpus identifies which failure modes have appeared, but the small sample size means the distribution of failure causes may shift significantly as more entries are added. The evidence depth classification makes this limitation explicit in every report.
US only — UK and NHS excluded
The corpus is US-focused. UK NHS procurement structures, commissioning pathways, and NICE approval processes differ structurally from US payer and provider dynamics. Including NHS-specific failures would require a separate failure taxonomy, separate sub-vertical definitions, and separate base rate calibration. This is a known scope limitation, not a data gap that can be patched with additional entries.
Companies operating in both US and UK markets are included only if the failure mechanism was primarily US-driven. If the UK regulatory pathway was the primary cause of failure, the entry is excluded.
Future corpus expansion to cover UK NHS dynamics would require a distinct set of sub-vertical definitions, a separate base rate calibration for NHS procurement timelines, and an independent failure taxonomy for NHS-specific failure mechanisms such as ICS commissioning failure, QIPP budget displacement, and NICE evidence gap. That work is not yet scoped.
Similarly, the corpus does not include European markets, Canadian provincial health systems, or Asia-Pacific healthcare markets. Each system has structurally distinct procurement, reimbursement, and regulatory dynamics that would require independent taxonomy development before corpus entries could be reliably compared.
Coverage summary: 15 sub-verticals · 241 confirmed failures · Saturated threshold: 20+ entries. Sub-verticals below threshold produce THIN evidence depth classifications. US only — UK/NHS dynamics excluded.
Related methodology